Остеоартрит суставов позвоночника как причина хронической боли в нижней части спины

Хроническая неспецифическая боль в нижней части спины (ХНБС) представляет серьезную медицинскую и социальную проблему, являясь одной из основных причин инвалидизации и значительного снижения качества жизни людей в современной популяции. Разработка эффективных методов лечения ХНБС требует совместных усилий представителей разных медицинских специальностей: терапевтов, ревматологов, неврологов, нейрохирургов и реабилитологов. Одной из частых причин развития ХНБС следует считать остеоартрит фасеточных и крестцово-подвздошных суставов. Авторы рассматривают вопросы патогенеза и клинических проявлений, проблемы диагностики, а также различные подходы к лечению данной патологии. На основании  собственного опыта и анализа данных литературы определены ряд положений, которые в дальнейшем могут использоваться для формирования рекомендаций по лечению и реабилитации больных с ХНБС.

хроническая неспецифическая боль в спине, остеоартрит, фасеточные суставы, крестцовоподвздошные суставы, нестероидные противовоспалительные препараты, глюкокортикоиды, гиалуроновая кислота, радиочастотная денервация

1. Яхно НН, Кукушкин МЛ, редакторы. Боль (практическое руководство для врачей). Москва: Издательство РАМН; 2012. 512 c.

2. Knezevic NN, Mandalia S, Raasch J, et al. Treatment of chronic low back pain – new approaches on the horizon. J Pain Res. 2017 May 10;10:1111-23. doi: 10.2147/JPR.S132769. eCollection 2017.

3. Wong AY, Karppinen J, Samartzis D. Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord. 2017 Apr 18;12:14. doi: 10.1186/s13013-017-0121-3.eCollection 2017.

4. Last AR, Hulberta K. Chronic Low Back Pain: Evaluation and Management. Am Fam Physician. 2009;79(12):1067-74.

5. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic anlysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.

6. Allegri M, Montella S, Salici F, et al. Mechanisms of low back pain: a guide for diagnosis and therapy. Version 2. F1000Res. 2016 Jun 28 [revised 2016 Oct 11];5. pii: F1000 Faculty Rev-1530. eCollection 2016.

7. Shmagel A, Foley R, Ibrahim H. Epidemiology of Chronic Low Back Pain in US Adults: Data From the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken). 2016 Nov;68(11):1688-94. doi: 10.1002/acr.22890

8. Deyo R, Mirza S, Turner J, Martin B. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009;22(1):62-8.

9. Давыдов ОС. Остеоартрит фасеточных суставов как одна из составляющих неспецифической боли в спине. Неврология, нейропсихиатрия, психосоматика. 2019;11(2S):76-82 doi: 10.14412/2074-2711-2019-2S-76-82

10. Исайкин АИ, Давыдов ОС, Кавелина АВ, Иванова МА. Проблема спондилоартроза. Взгляд невролога. Эффективная фармакотерапия. 2017;38(5):28-40

11. Perolat R, Kastler A, Nicot B, et al. Facet joint syndrome: from diagnosis to interventional management. Insights Imaging. 2018 Oct;9(5):773-89. doi: 10.1007/s13244-018-0638-x. Epub 2018 Aug 8.

12. Gellhorn AC, Katz JN, Suri P. Osteoarthritis of the spine: the facet joints. Nat Rev Rheumatol. 2013 Apr;9(4):216-24. doi: 10.1038/nrrheum.2012.199. Epub 2012 Nov 13.

13. Cavanaugh JM, Lu Y, Chen C, Kallakuri S. Pain generation in lumbar and cervical facet joints. J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:63-7.

14. Ita ME, Zhang S, Holsgrove TP, et al. The Physiological Basis of Cervical Facet-Mediated Persistent Pain: Basic Science and Clinical Challenges. J Orthop Sports Phys Ther. 2017 Jul;47(7):450-61. doi: 10.2519/jospt.2017.7255. Epub 2017 Jun 16.

15. Zhang S, Zhao E, Winkelstein BA. A Nociceptive Role for Integrin Signaling in Pain After Mechanical Injury to the Spinal Facet Capsular Ligament. Ann Biomed Eng. 2017 Dec;45(12):2813-25. doi: 10.1007/s10439-017-1917-2. Epub 2017 Sep 18.

16. Kalichman L, Kim DH, Li L, et al. Computed tomography-evaluated features of spinal degeneration: prevalence, intercorrelation, and association with self-reported low back pain. Spine J. 2010 Mar;10(3):200-8. doi: 10.1016/j.spinee.2009.10.018. Epub 2009 Dec 16.

17. Goode AP, Marshall SW, Renner JB, et al. Lumbar spine radiographic features and demographic, clinical, and radiographic knee, hip, and hand osteoarthritis. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1536-44. doi: 10.1002/acr.21720

18. Eubanks JD, Lee MJ, Cassinelli E, Ahn NU. Prevalence of lumbar facet arthrosis and its relationship to age, sex, and race: an anatomic study of cadaveric specimens. Spine (Phila Pa 1976). 2007 Sep 1;32(19):2058-62.

19. Ko S, Vaccaro AR, Lee S, et al. The prevalence of lumbar spine facet joint osteoarthritis and its association with low back pain in selected Korean populations. Clin Orthop Surg. 2014 Dec;6(4):385-91. doi: 10.4055/cios.2014.6.4.385. Epub 2014 Nov 10.

20. Maataoui A, Vogl TJ, Middendorp M, et al. Association between facet joint osteoarthritis and the Oswestry Disability Index. World J Radiol. 2014 Nov 28;6(11):881-5.

21. Schwarzer AC, Derby R, Aprill CN, et al. The value of the provocation response in lumbar zygapophyseal joint injections. Clin J Pain. 1994 Dec;10(4):309-13.

22. Manchikanti L, Boswell MV, Singh V, et al. Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord. 2004 May 28;5:15.

23. Mooney V, Robertson J. The facet syndrome. Clin Orthop Relat Res. 1976 Mar-Apr;(115):149-56.

24. Gomez Vega JC, Acevedo-Gonzalez JC. Clinical diagnosis scale for pain lumbar of facet origin: systematic review of literature and pilot study. Neurocirugia (Astur). 2018 Jun 14. pii: S1130-1473(18)30051-4

25. Vleeming A, Schuenke MD, Masi AT, et al. The sacroiliac joint: an overview of its anatomy, function and potential clinical implications. J Anat. 2012 Dec;221(6):537-67. doi: 10.1111/j.1469-7580.2012.01564.x. Epub 2012 Sep 19.

26. Forst SL, Wheeler MT, Fortin JD, Vilensky JA. The sacroiliac joint: anatomy, physiology and clinical significance. Pain Physician. 2006 Jan;9(1):61-7

27. Polly DW Jr. The Sacroiliac Joint. Neurosurg Clin N Am. 2017 Jul;28(3):301-12. doi: 10.1016/j.nec.2017.03.003

28. Исайкин АИ, Иванова МА, Кавелина АВ, Черненко ОА, Яхно НН. Синдром крестцово-подвздошного сочленения. Русский медицинский журнал. 2016;24:1583-8

29. Asada M, Tokunaga D, Arai Y, et al. Degeneration of the Sacroiliac Joint in Hip Osteoarthritis Patients: A Three-Dimensional Image Analysis. J Belg Soc Radiol. 2019 May 23;103(1):36. doi: 10.5334/jbsr.1648

30. Weinberg DS, Gebhart JJ, Liu RW. Hip-spine syndrome: A cadaveric analysis between osteoarthritis of the lumbar spine and hip joints. Orthop Traumatol Surg Res. 2017 Sep;103(5):651-6. doi: 10.1016/j.otsr.2017.05.010. Epub 2017 May 31.

31. Laplante BL, DePalma MJ. Spine osteoarthritis. PMR. 2012 May;4(5 Suppl):S28-36. doi: 10.1016/j.pmrj.2012.03.005

32. Kampen WU, Tillmann B. Age-related changes in the articular cartilage of human sacroiliac joint. Anat Embryol (Berl). 1998 Dec;198(6):505-13.

33. Cohen SP, Chen Y, Neufeld NJ. Sacroiliac joint pain: a comprehensive review of epidemiology, diagnosis and treatment. Expert Rev Neurother. 2013 Jan;13(1):99-116. doi: 10.1586/ern.12.148

34. Hodge JC, Bessette B. The incidence of sacroiliac joint disease in patients with low-back pain. Can Assoc Radiol J. 1999 Oct;50(5):321-3.

35. Shibata Y, Shirai Y, Miyamoto M. The aging process in the sacroiliac joint: helical computed tomography analysis. J Orthop Sci. 2002;7(1):12-8.

36. Vogler JB 3rd, Brown WH, Helms CA, Genant HK. The normal sacroiliac joint: a CT study of asymptomatic patients. Radiology. 1984 May;151(2):433-7.

37. Maigne JY, Aivaliklis A, Pfefer F. Results of sacroiliac joint double block and value of sacroiliac pain provocation tests in 54 patients with low back pain. Spine (Phila Pa 1976). 1996;21:1889-92.

38. Simopoulos TT, Manchikanti L, Gupta S, et al. Systematic Review of the Diagnostic Accuracy and Therapeutic Effectiveness of Sacroiliac Joint Interventions. Pain Physician. 2015 SepOct;18(5):E713-56.

39. Barros G, McGrath L, Gelfenbeyn M. Sacroiliac Joint Dysfunction in Patients With Low Back Pain. Fed Pract. 2019 Aug;36(8):370-5.

40. Rupert MP, Lee M, Manchikanti L, et al. Evaluation of sacroiliac joint interventions: a systematic appraisal of the literature. Pain Physician. 2009 Mar-Apr;12(2):399-418.

41. Szadek KM, van der Wurff P, van Tulder MW, et al. Diagnostic validity of criteria for sacroiliac joint pain: a systematic review. J Pain. 2009 Apr;10(4):354-68. doi: 10.1016/j.jpain.2008.09.014. Epub 2008 Dec 19.

42. Насонов ЕЛ, редактор. Российские клинические рекомендации. Ревматология. Москва: ГЭОТАР-Медиа; 2017. 464 с.

43. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Jul 3. pii: S1063-4584(19)31116-1. doi: 10.1016/j.joca.2019.06.011 [Epub ahead of print].

44. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Apr 30. pii: S0049-0172(19)30043-5. doi: 10.1016/j.semarthrit.2019.04.008 [Epub ahead of print].

45. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005 May;64(5):669-81. Epub 2004 Oct 7.

46. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74.

47. Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Apr 4;166(7):514-30. doi: 10.7326/M16-2367. Epub 2017 Feb 14.

48. Bernstein IA, Malik Q, Carville S, Ward S. Low back pain and sciatica: summary of NICE guidance. BMJ. 2017 Jan 6;356:i6748. doi: 10.1136/bmj.i6748

49. Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018 Jun 9;391(10137):2368-83. doi: 10.1016/S0140-6736(18)30489-6. Epub 2018 Mar 21.

50. Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018 Nov;27(11):2791-803. doi: 10.1007/s00586-018-5673-2. Epub 2018 Jul 3.

51. Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019 Feb 25;2:CD013273. doi: 10.1002/14651858.CD013273

52. Saragiotto BT, Machado GC, Ferreira ML, et al. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016 Jun 7;(6):CD012230. doi: 10.1002/14651858.CD012230

53. De Abajo FJ, Gil MJ, Bryant V, et al. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol. 2013 Mar;69(3):691-701. doi: 10.1007/s00228-012-1386-3. Epub 2012 Sep 6.

54. McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol – a review. Br J Clin Pharmacol. 2018 Oct;84(10):2218-30. doi: 10.1111/bcp.13656. Epub 2018 Jul 20.

55. Girard P, Sourdet S, Cantet C, et al. Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study. J Am Geriatr Soc. 2019 Jun;67(6):1240-7. doi: 10.1111/jgs.15861. Epub 2019 Mar 26.

56. Da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017 Jul 8;390(10090):e21-e33. doi: 10.1016/S0140-6736(17)31744-0

57. Jung SY, Jang EJ, Nam SW, et al. Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: A network meta-analysis. Mod Rheumatol. 2018 Nov;28(6):1021-8.

58. Moss P, Benson HAE, Will R, Wright A. Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial. Osteoarthritis Cartilage. 2017 Aug 2. pii: S1063-4584(17)31091-9

59. Arendt-Nielsen L, Egsgaard LL, Petersen KK. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. Pain. 2016 Aug;157(8):1634-44. doi: 10.1097/j.pain.0000000000000562

60. Cannon C, Curtis S, FitzGerald G, et al. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet. 2006;368:1771-81 Epub 2006 Nov 13.

61. Reginster J, Malmstrom K, Mehta A, et al. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann Rheum Dis. 2007;66(7):945-51.

62. Feng X, Tian M, Zhang W, Mei H. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis. PLoS One. 2018 Jan 10;13(1):e0190798. doi: 10.1371/journal.pone.0190798. eCollection 2018.

63. Gunter BR, Butler KA, Wallace RL, et al. Non-steroidal antiinflammatory drug-induced cardiovascular adverse events: a metaanalysis. J Clin Pharm Ther. 2017 Feb;42(1):27-38. doi: 10.1111/jcpt.12484. Epub 2016 Dec 26.

64. Zingler G, Hermann B, Fischer T, Herdegen T. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks. Expert Rev Clin Pharmacol. 2016 Nov;9(11):1479-92. doi: 10.1080/17512433.2016.1230495. Epub 2016 Sep 8.

65. Van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine (Phila Pa 1976). 2003 Sep 1;28(17):1978-92.

66. Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain. 2017 Feb;21(2):228-37. doi: 10.1002/ejp.907. Epub 2016 Jun 22.

67. Trouvin AP, Berenbaum F, Perrot S. The opioid epidemic: helping rheumatologists prevent a crisis. RMD Open. 2019 Aug 6;5(2):e001029. doi: 10.1136/rmdopen-2019-001029.eCollection 2019.

68. Smith SR, Deshpande BR, Collins JE, et al. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage. 2016 Jun;24(6):962-72.

69. Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Jul 1;176(7):958-68. doi: 10.1001/jamainternmed.2016.1251

70. Zhu X, Wu D, Sang L, et al. Comparative effectiveness of glucosamine, chondroitin, acetaminophen or celecoxib for the treatment of knee and/or hip osteoarthritis: a network meta-analysis. Clin Exp Rheumatol. 2018 Jul-Aug;36(4):595-602. Epub 2018 Jan 31.

71. Sodha R, Sivanadarajah N, Alam M. The use of glucosamine for chronic low back pain: a systematic review of randomised control trials. BMJ Open. 2013 Jun 20;3(6). pii: e001167. doi: 10.1136/bmjopen-2012-001167

72. Wilkens P, Scheel IB, Grundnes O, et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA. 2010 Jul 7;304(1):45-52. doi: 10.1001/jama.2010.893

73. Левин ОС, Олюнин ДЮ, Голубева ЛВ. Эффективность алфлутопа при хронической вертеброгенной люмбоишалгии по данным двойного слепого плацебо-контролируемого исследования. Научно-практическая ревматология. 2004;42(4):80-4 doi: 10.14412/1995-4484-2004-809

74. Лила АМ, Мазуров ВИ, Шидловская ОВ, Шостак МС. Терафлекс в комплексной терапии остеоартроза коленных суставов и позвоночника (результаты клинического исследования). Русский медицинский журнал. 2005;13(24):1618-22

75. Ковальчук ВВ, Миннуллин ТИ, Аманова ЭО и др. Пациент с болью в спине в практике клинициста. Возможности повышения эффективности терапии. Поликлиника. 2016;(3-4): 62-72

76. Алексеева ЛИ, Алексеев ВВ, Баринов АН, Сингх Г. Новые подходы к лечению неспецифической боли в нижней части спины. Научно-практическая ревматология. 2016;54(1):16-20 doi: 10.14412/1995-4484-2016-16-20

77. Jü ni P, Hari R, Rutjes AW, et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015 Oct 22;(10):CD005328.

78. McAlindon TE, LaValley MP, Harvey WF, et al. Effect of Intraarticular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2017 May 16;317(19):1967-75. doi: 10.1001/jama.2017.5283

79. Manchikanti L, Kaye AD, Boswell MV, et al. A Systematic Review and Best Evidence Synthesis of the Effectiveness of Therapeutic Facet Joint Interventions in Managing Chronic Spinal Pain. Pain Physician. 2015 Jul-Aug;18(4):E535-82.

80. Vekaria R, Bhatt R, Ellard DR, et al. Intra-articular facet joint injections for low back pain: a systematic review. Eur Spine J. 2016 Apr;25(4):1266-81. doi: 10.1007/s00586-016-4455-y. Epub 2016 Feb 23.

81. Kennedy DJ, Huynh L, Wong J, et al. Corticosteroid Injections Into Lumbar Facet Joints: A Prospective, Randomized, DoubleBlind Placebo-Controlled Trial. Am J Phys Med Rehabil. 2018 Oct;97(10):741-6. doi: 10.1097/PHM.0000000000000960

82. Sae-Jung S, Jirarattanaphochai K. Outcomes of lumbar facet syndrome treated with oral diclofenac or methylprednisolone facet injection: a randomized trial. Int Orthop. 2016 Jun;40(6):1091-8. doi: 10.1007/s00264-016-3154-y. Epub 2016 Mar 18.

83. Hansen H, Manchikanti L, Simopoulos TT, et al. A systematic evaluation of the therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2012 May-Jun;15(3):E247-78.

84. Fuchs S, Erbe T, Fischer HL, et al. Intraarticular hyaluronic acid versus glucocorticoid injections for nonradicular pain in the lumbar spine. J Vasc Interv Radiol. 2005 Nov;16(11):1493-8.

85. DePalma MJ, Ketchum JM, Queler ED, Trussell BS. Prospective pilot study of painful lumbar facet joint arthropathy after intraarticular injection of hylan G-F 20. PMR. 2009 Oct;1(10):908-15. doi: 10.1016/j.pmrj.2009.09.008

86. Cleary M, Keating C, Poynton AR. Viscosupplementation in lumbar facet joint arthropathy: a pilot study. J Spinal Disord Tech. 2008 Feb;21(1):29-32. doi: 10.1097/BSD.0b013e318057720c

87. Annaswamy TM, Armstead C, Carlson L, et al. Intra-articular Triamcinolone Versus Hyaluronate Injections for Low Back Pain With Symptoms Suggestive of Lumbar Zygapophyseal Joint Arthropathy: A Pragmatic, Double-Blind Randomized Controlled Trial. Am J Phys Med Rehabil. 2018 Apr;97(4):278-84. doi: 10.1097/PHM.0000000000000879

88. Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: a new concept in the treatment of sacroiliac joint syndrome: a preliminary report of four cases. Reg Anesth Pain Med. 1999 Jan-Feb;24(1):84-8.

89. O'Connell B, Wragg NM, Wilson SL. The use of PRP injections in the management of knee osteoarthritis. Cell Tissue Res. 2019 May;376(2):143-52. doi: 10.1007/s00441-019-02996-x. Epub 2019 Feb 13.

90. Wu J, Zhou J, Liu C, et al. A Prospective Study Comparing Platelet-Rich Plasma and Local Anesthetic (LA)/Corticosteroid in Intra-Articular Injection for the Treatment of Lumbar Facet Joint Syndrome. Pain Pract. 2017 Sep;17(7):914-24. doi: 10.1111/papr.12544. Epub 2017 Feb 22.

91. Navani A, Manchikanti L, Albers SL, et al. Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2019 Jan;22(1S):S1-S74.

92. Maas ET, Ostelo RW, Niemisto L, et al. Radiofrequency denervation for chronic low back pain. Cochrane Database Syst Rev. 2015 Oct 23;(10):CD008572. doi: 10.1002/14651858.CD008572.pub2

93. Juch JN, Maas ET, Ostelo RWJG, et al. Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials. JAMA. 2017 Jul 4;318(1):68-81. doi: 10.1001/jama.2017.7918

94. Do KH, Ahn SH, Cho YW, Chang MC. Comparison of intra-articular lumbar facet joint pulsed radiofrequency and intra-articular lumbar facet joint corticosteroid injection for management of lumbar facet joint pain: A randomized controlled trial. Medicine (Baltimore). 2017 Mar;96(13):e6524. doi: 10.1097/MD.0000000000006524

95. Burmester GR, Bijlsma JWJ, Cutolo M, McInnes IB. Managing rheumatic and musculoskeletal diseases – past, present and future. Nat Rev Rheumatol. 2017 Jul;13(7):443-8. doi: 10.1038/nrrheum.2017.95. Epub 2017 Jun 15.

96. Clauw DJ, Essex MN, Pitman V, Jones KD. Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management. Postgrad Med. 2019 Jan;131(3):1-14. doi: 10.1080/00325481.2019.1574403 [Epub ahead of print].

97. Rausch Osthoff AK, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018 Sep;77(9): 1251-60. doi: 10.1136/annrheumdis-2018-213585. Epub 2018 Jul 11.

98. Jauregui JJ, Cherian JJ, Gwam CU, et al. A Meta-Analysis of Transcutaneous Electrical Nerve Stimulation for Chronic Low Back Pain. Surg Technol Int. 2016 Apr;28:296-302.

99. Resende L, Merriwether E, Rampazo EP, et al. Meta-analysis of transcutaneous electrical nerve stimulation for relief of spinal pain. Eur J Pain. 2018 Apr;22(4):663-78. doi: 10.1002/ejp.1168. Epub 2017 Dec 27.

100. Lam M, Galvin R, Curry P. Effectiveness of acupuncture for nonspecific chronic low back pain: a systematic review and metaanalysis. Spine (Phila Pa 1976). 2013 Nov 15;38(24):2124-38. doi: 10.1097/01.brs.0000435025.65564.b7

101. Coulter ID, Crawford C, Hurwitz EL, et al. Manipulation and mobilization for treating chronic low back pain: a systematic review and meta-analysis. Spine J. 2018 May;18(5):866-79. doi: 10.1016/j.spinee.2018.01.013. Epub 2018 Jan 31.

102. Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M.

103. Massage for low-back pain. Cochrane Database Syst Rev. 2015 Sep 1;(9):CD001929. doi: 10.1002/14651858.CD001929.pub3

104. Meng XG, Yue SW. Efficacy of aerobic exercise for treatment of chronic low back pain: a meta-analysis. Am J Phys Med Rehabil. 2015 May;94(5):358-65. doi: 10.1097/PHM.0000000000000188

105. Lingutla KK, Pollock R, Ahuja S. Sacroiliac joint fusion for low back pain: a systematic review and meta-analysis. Eur Spine J. 2016 Jun;25(6):1924-31. doi: 10.1007/s00586-016-4490-8. Epub 2016 Mar 8.

106. Polly DW, Cher DJ, Wine KD, et al. Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion Using Triangular Titanium Implants vs Nonsurgical Management for Sacroiliac Joint Dysfunction: 12-Month Outcomes. Neurosurgery. 2015 Nov; 77(5):674-90; discussion 690-1. doi: 10.1227/NEU.0000000000000988